Edition:
United Kingdom

Income Statements: Arvinas Inc (ARVN.OQ)

ARVN.OQ on NASDAQ Stock Exchange Global Select Market

24.41USD
19 Jul 2019
Change (% chg)

$-0.07 (-0.29%)
Prev Close
$24.48
Open
$24.42
Day's High
$24.66
Day's Low
$24.07
Volume
29,028
Avg. Vol
61,595
52-wk High
$27.79
52-wk Low
$10.22

Interim Income Statement
View: AnnualInterim

In Millions ofU.S. Dollars
(except for per share items)
2019
2019-03-31
Period Length
3 Months
Revenue 4.0
Other Revenue, Total --
Total Revenue 4.0
Cost of Revenue, Total --
Gross Profit --
Selling/General/Admin. Expenses, Total 5.6
Research & Development 14.2
Depreciation/Amortization --
Interest Expense, Net - Operating --
Interest/Investment Income - Operating --
Interest Expense(Income) - Net Operating --
Unusual Expense (Income) --
Other Operating Expenses, Total --
Total Operating Expense 19.8
Operating Income (15.8)
Interest Expense, Net Non-Operating (0.0)
Interest/Invest Income - Non-Operating 1.2
Interest Income(Exp), Net Non-Operating --
Gain (Loss) on Sale of Assets --
Other, Net 0.2
Net Income Before Taxes (14.4)
Provision for Income Taxes --
Net Income After Taxes (14.4)
Minority Interest --
Equity In Affiliates --
U.S. GAAP Adjustment --
Net Income Before Extra. Items (14.4)
Accounting Change --
Discontinued Operations --
Extraordinary Item --
Tax on Extraordinary Items --
Net Income (14.4)
Preferred Dividends 0.0
General Partners' Distributions --
Miscellaneous Earnings Adjustment --
Pro Forma Adjustment --
Interest Adjustment - Primary EPS --
Income Available to Com Excl ExtraOrd (14.4)
Income Available to Com Incl ExtraOrd (14.4)
Basic Weighted Average Shares 31.33
Basic EPS Excluding Extraordinary Items (0.460)
Basic EPS Including Extraordinary Items (0.460)
Dilution Adjustment --
Diluted Weighted Average Shares 31.33
Diluted EPS Excluding ExtraOrd Items (0.460)
Diluted EPS Including ExtraOrd Items (0.460)
DPS - Common Stock Primary Issue 0.000
Gross Dividends - Common Stock 0.0
Total Special Items --
Normalized Income Before Taxes (14.4)
Effect of Special Items on Income Taxes --
Inc Tax Ex Impact of Sp Items --
Normalized Income After Taxes (14.4)
Normalized Inc. Avail to Com. (14.4)
Basic Normalized EPS (0.460)
Diluted Normalized EPS (0.460)

Bayer teams up with biotech firm Arvinas in deal worth up to $750 mln

FRANKFURT, June 4 German drugmaker Bayer has signed an alliance with Arvinas Inc to gain access to the U.S. biotech firm's experimental protein drugs and crop protection technology in a deal worth up to $750 million.